Health
Republican Voters Support Medicaid but Want Work Requirements, Poll Finds
As Congressional Republicans weigh major cuts to Medicaid, most voters do not want to see the public health plan’s funding dialed back, according to a poll released Friday by KFF, a nonpartisan health research firm.
Just 17 percent of respondents said they supported cuts to Medicaid, the government health insurance program that covers more than 70 million people. Forty percent said they wanted to keep spending unchanged, and 42 percent said they would like it increased.
But at the same time, the poll found significant support for certain policies that would limit the program, such as requiring enrollees to work. More than 60 percent of voters — and 47 percent of Democrats — supported a work requirement, the poll found.
That change, which has been championed by some congressional Republicans, is estimated to cut about $100 billion from Medicaid, as those who were unemployed — or could not file the paperwork showing they had a job — would no longer be covered. The program’s cost was $584 billion in 2024, or about 8 percent of total federal spending.
The poll also illustrated Medicaid’s wide reach, with just over half of respondents saying that either they or a family member had at one point had Medicaid coverage. There was nearly universal agreement that Medicaid mattered to voters’ local communities, with 98 percent of Democrats and 94 percent of Republicans saying they thought it was somewhat or very important.
Republicans in Congress are considering several changes to Medicaid as they look for ways to pay for President Trump’s tax cuts. Last month, the House passed a budget that, if approved by the Senate and signed by the president, could trim as much as $880 billion from the program over the next decade. That could happen with work requirements, caps on federal spending for the program, or reducing the share of costs the federal government pays.
Although poll respondents were generally in favor of work requirements, they held misconceptions about the policy: Sixty-two percent of voters thought that most Medicaid enrollees are unemployed, when in fact a vast majority have jobs.
Republican voters also expressed an openness to cutting funding for the Affordable Care Act Medicaid expansion. Right now, the federal government pays 90 percent of the costs for participants in the expansion, who tend to be healthy adults. That is a higher share than what it covers for other enrollees, such as children or disabled people.
Sixty-four percent of Republican voters — and 40 percent of voters overall — said they would support reducing the federal government’s contribution to Medicaid expansion. House Republicans continue to weigh this option, even though Speaker Mike Johnson said last week it was not on the table.
Voters’ opinions on reducing Medicaid expansion funding seemed malleable, however, in the face of additional information.
When respondents were given more information about the policy, including the fact that millions could lose coverage, Republican support fell to 43 percent. But being told that the change would cut federal spending by about $600 billion increased support to 73 percent.
The polling looks similar to what Americans felt during the Affordable Care Act repeal debate in 2017, when Republicans failed to roll back the law in large part because of political opposition to Medicaid cuts. Back then, 70 percent of voters supported work requirements and 36 percent favored cutting Medicaid expansion funding.
“Medicaid is a very popular program among a wide swath of the public including Republicans,” said Mollyann Brodie, KFF’s executive director of survey research.
But, she added, “opinions could be quickly moved in the context of debate where people learn more information and feel their coverage is threatened.”
NEWYou can now listen to Fox News articles!
Top stories
→ Former wrestler, actor reveals breast cancer diagnosis: ‘One in 750 men’
→ TV news anchorman reveals he has Alzheimer’s during final night helming broadcast
Former professional wrestler and actor Tyler Mane announced he has been diagnosed with breast cancer. (Dimitrios Kambouris/Getty Images)
FOLLOW US ON FACEBOOK
Conversation starters
→ Nightly glass of wine may not be as harmless as many people think, study suggests
→ Bride in full wedding gown makes 2-hour hospital trip to see mother before ceremony
Healthy habits
→ Weekly weightlifting sweet spot may be linked to longer life, study finds
→ Americans to get new sunscreen option already used abroad for decades
CLICK HERE FOR MORE HEALTH STORIES
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
NEWYou can now listen to Fox News articles!
Taking a GLP-1 medication for weight loss may improve male fertility, according to experts.
Research presented this week at ENDO 2026, the Endocrine Society’s annual meeting in Chicago, explored how obesity is strongly linked to fertility problems in men.
Excess weight can contribute to dysregulation of the hypothalamic-pituitary-gonadal (HPG) axis — the hormone system that regulates testosterone production — and functional hypogonadism, a condition in which testosterone levels are abnormally low because of disrupted hormone signaling. These changes can also impair semen quality.
WEIGHT-LOSS MEDICATIONS COULD IMPACT SEXUAL HEALTH IN UNEXPECTED WAYS
The researchers evaluated how GLP-1 weight-loss drugs impact reproductive hormones and metabolic outcomes, analyzing data of men between the ages of 18 and 65 who were taking one of the medications, according to a press release.
The systematic review of five randomized controlled trials focused on measuring testosterone, brain hormones involved in testosterone and sperm production, and a protein that carries sex hormones in the blood. Semen quality, weight and BMI, cholesterol and blood sugar were also measured.
Men with obesity and low testosterone linked to obesity may experience improved testosterone, sperm quality and metabolic heath while taking a GLP-1, the study found. (iStock)
The results suggested that GLP-1 medications do not suppress male hormones. Men with obesity and low testosterone linked to obesity may experience improved testosterone, sperm quality and metabolic health, especially during weight loss.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
In one four-week study, dulaglutide showed no significant changes in reproductive hormones or sexual function.
In a separate 16-week trial, liraglutide improved hormones in obese men with functional hypogonadism, meaning low testosterone was likely related to obesity. The review found that liraglutide was better for health outcomes than hormone replacement therapy.
CLICK HERE FOR MORE HEALTH STORIES
Another liraglutide study reported improved sperm concentration and count.
The study authors concluded that GLP-1s “do not appear to acutely suppress the male HPG axis and may improve reproductive hormones and semen parameters in obese hypogonadal men, largely within the context of weight loss.” (iStock)
A 24-week trial of semaglutide, known commercially as Ozempic and Wegovy, saw improvement in sperm shape and bad cholesterol, while preserving total testosterone.
As only five trials were included, the small evidence base suggests more research is necessary to prove further association.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
In an abstract of the research, the authors summed up that GLP-1s “do not appear to acutely suppress the male HPG axis and may improve reproductive hormones and semen parameters in obese hypogonadal men, largely within the context of weight loss.”
“However, evidence remains limited and heterogeneous, underscoring the need for larger RCTs explicitly powered to assess male reproductive outcomes,” they wrote.
“This provides early evidence that GLP-1 medications taken by obese men with hypogonadism/low testosterone (low T) improves testosterone levels,” one doctor said. (iStock)
Dr. Anthony Puopolo, men’s health expert and lead medical provider for RexMD, reflected on these findings in an interview with Fox News Digital.
“This provides early evidence that GLP-1 medications taken by obese men with hypogonadism/low testosterone (low T) improves testosterone levels,” he said.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
While more research is necessary, Pupolo, who was not involved in the study, shared his optimism about how GLP-1s can play a role in improving male fertility.
“If this finding continues to gain evidence, GLP-1s might be a better option for low T than testosterone replacement therapy (TRT) in obese men – as GLP-1 medications preserve fertility, whereas TRT tends to be harmful to male reproductive/sperm function,” he added.
-
Los Angeles, Ca9 minutes agoKids, teens can enjoy free lunch at over 90 parks across Los Angeles
-
Detroit, MI27 minutes agoMetro Detroit church hosts community event to support youth: “We’re here for you”
-
San Francisco, CA39 minutes agoSan Francisco celebrates Black freedom at weekend Juneteenth parade: ‘We’re all people’
-
Dallas, TX42 minutes agoRedesign debate intensifies as Dallas convention center faces costly delays
-
Miami, FL47 minutes ago‘An insane memory’: New World Cup super hero plays in Miami but not with Messi
-
Boston, MA54 minutes agoFAA investigates close call between two aircraft at intersecting runways at Boston Logan International Airport | CNN
-
Denver, CO56 minutes agoProposed September 2026 Service Changes
-
Seattle, WA1 hour agoSeattle gets a heat wave and rain storm in the same week? – Emerald City Weather Blog
